Aytu Biopharma Inc (AYTU)

Finanzdaten der Aytu Biopharma Inc-Aktie (AYTU)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	21.54% 17.99	22.93	22.10	30.73	22.73
Cost Of Revenue	6.40% 6.30	6.731	7.315	12.17	9.99
Gross Profit	27.83% 11.69	16.20	14.78	18.56	12.74
Operating Expenses	2.30% 14.16	13.84	16.29	18.39	21.30
Benefits Costs and Expenses	7.57% 20.64	22.33	30.22	33.19	29.93
Costs And Expenses	7.57% 20.64	22.33	30.22	33.19	29.93
Depreciation and Amortization	3.42% 1.834	1.899	1.941	-	-
Operating Income/Loss	204.23% -2.464	2.364	-1.504	0.169	-8.558
Income/Loss From Continuing Operations Before Tax	534.54% -2.642	0.608	-8.12	-2.457	-7.20
Income Tax Expense/Benefit	70.41% 0.245	0.828	-	-	-
Income/Loss From Continuing Operations After Tax	1,212% -2.887	-0.22	-8.12	-2.457	-7.20
Net Income/Loss	1,212% -2.887	-0.22	-8.12	-2.457	-7.20
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.29% 5.5336	5.5177	5.482	0.2408	3.7268
Basic Earnings Per Share	1,200% -0.52	-0.04	-1.48	-0.40	-1.93
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-